期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
雷珠单抗联合激光治疗糖尿病视网膜病变的疗效 被引量:24
1
作者 孟凡毅 任艳竹 张婉婷 《国际眼科杂志》 CAS 北大核心 2018年第4期638-641,共4页
目的:探讨雷珠单抗联合激光治疗增生型糖尿病视网膜病变(proliferative diabetic retinopathy,PDR)的临床疗效。方法:本研究观察对象为2014-10/2016-10我院眼科接诊的80例101眼PDR患者,按照治疗方式不同分为观察组与对照组。对照组40例5... 目的:探讨雷珠单抗联合激光治疗增生型糖尿病视网膜病变(proliferative diabetic retinopathy,PDR)的临床疗效。方法:本研究观察对象为2014-10/2016-10我院眼科接诊的80例101眼PDR患者,按照治疗方式不同分为观察组与对照组。对照组40例50眼只采用全视网膜激光光凝(panretinal photocoagulation,PRP)治疗,观察组40例51眼在此基础上术前使用雷珠单抗治疗。比较术前、术后1、3、6mo最佳矫正视力(best corrected visual acuity,BCVA),光学相干断层成像技术(optical coherence tomography,OCT)检查各时期黄斑中心凹厚度(central macular thickness,CMT)以及各时间视网膜新生血管面积,并比较两组患眼使用激光能量、光斑数以及能量密度,记录不良反应发生情况。结果:两组患者术后BCVA均显著改善,且观察组术后1、3、6mo均显著高于对照组,差异有统计学意义(P<0.05);两组患者治疗后CMT、新生血管面积较治疗前显著降低,且观察组术后1、3、6mo均显著低于对照组,差异均具有统计学意义(P<0.05);观察组使用激光能量、光斑数以及能量密度均显著低于对照组,差异具有统计学意义(P<0.05);观察组2例2眼,对照组1例1眼出现超过28mmHg眼压,卡替洛尔降压治疗3d后恢复正常,两组均未出现青光眼、视网膜脱离,眼内炎等其他并发症。结论:雷珠单抗联合激光治疗PDR能显著改善BCVA,降低CMT,消除新生血管,所需激光能量更低,安全有效。 展开更多
关键词 雷珠单抗 激光治疗 糖尿病视网膜病变
下载PDF
使用不同眼压计比较翼状胬肉术后绷带镜对眼压的影响 被引量:1
2
作者 黄明可 任保童 +2 位作者 任艳竹 孟凡毅 皮百木 《国际眼科杂志》 CAS 北大核心 2020年第6期1091-1094,共4页
目的:利用回弹式眼压计(RT)及非接触式眼压计(NCT)测量并比较翼状胬肉术后配戴治疗用绷带镜时与裸眼眼压的差异。方法:选取2019-04/06在开封市中心医院开封眼病医院手术治疗的翼状胬肉患者(鼻侧原发性翼状胬肉小于4mm且术后配戴治疗用... 目的:利用回弹式眼压计(RT)及非接触式眼压计(NCT)测量并比较翼状胬肉术后配戴治疗用绷带镜时与裸眼眼压的差异。方法:选取2019-04/06在开封市中心医院开封眼病医院手术治疗的翼状胬肉患者(鼻侧原发性翼状胬肉小于4mm且术后配戴治疗用绷带镜)50例50眼。于术后14d用RT及NCT分别在戴镜状态、裸眼状态测量患者眼压,比较并分析翼状胬肉术后治疗用绷带镜对眼压测量的影响。结果:RT在戴镜状态、裸眼状态测得的眼压分别为18.20±3.19、15.17±3.80mmHg,相差3.04±1.79mmHg,且前后两次测量具有良好的相关性(r=0.884,P<0.001);NCT在戴镜状态、裸眼状态测得的眼压分别为15.74±3.23、13.19±3.89mmHg,相差2.55±1.88mmHg,且具有良好的相关性(r=0.876,P<0.001);在戴镜状态及裸眼状态,两种设备测量所得眼压分别相差2.46±1.45、1.98±1.67mmHg,RT测量结果均显著高于NCT测量结果(P<0.001)。结论:翼状胬肉术后应用RT、NCT测量配戴治疗用绷带镜状态与裸眼状态的眼压一致性均较好,但在配戴治疗用绷带镜时两种眼压计均有高估患者眼压风险,且应用RT在戴镜状态及裸眼状态眼压高估较NCT更明显。 展开更多
关键词 翼状胬肉切除手术 治疗用绷带镜 眼压 回弹式眼压计 非接触眼压计
下载PDF
The Role of Chinese Medicine in Cancer Care——a Critical Review
3
作者 Dan Jiang fan-yi meng +1 位作者 Lily Li Fan Qu 《World Journal of Traditional Chinese Medicine》 2016年第1期68-73,共6页
Traditional Chinese medicine(TCM) has been widely used in China and other East Asian countries for helping cancer patients. However, it is unavailable to most patients who are treated in NHS in UK, due to there is not... Traditional Chinese medicine(TCM) has been widely used in China and other East Asian countries for helping cancer patients. However, it is unavailable to most patients who are treated in NHS in UK, due to there is not enough evidence in using TCM in cancer patients, To try to establish the evidence base for using TCM in cancer patients management, the author reviewed the current available clinical reports to TCM treatment of cancer patients, mainly those of randomly assigned and controlled clinical trials(RCTs) with bigger samples, from maintaining the quality of life, enhancing immune system, remedying the side effects from radiotherapy and chemotherapy respectively, and to propose a role of TCM as an assistant therapy to the main therapies. We then concluded that TCM holds its unique value in maintaining good quality of life, and to help the patients through the operation, chemotherapy and radiotherapy to achieve better outcomes. 展开更多
关键词 Traditional Chinese medicine(TCM) CANCER quality of life
原文传递
Meshed acellular dermal matrix:technique and application in implant based breast reconstruction
4
作者 Dino Zammit Jonathan Kanevsky +1 位作者 fan-yi meng Tassos Dionisopoulos 《Plastic and Aesthetic Research》 2016年第1期254-256,共3页
Alloderm was the first acellular dermal matrix used and remains a popular choice among plastic surgeons.However,while the overall surgical outcome of breast reconstruction using alloderm has been a success,the economi... Alloderm was the first acellular dermal matrix used and remains a popular choice among plastic surgeons.However,while the overall surgical outcome of breast reconstruction using alloderm has been a success,the economic burden on the health care system makes it a subject of frequent re-evaluations in cost-effectiveness.Prompted by the high price of$3,700 USD for a 6 cm×16 cm area,our group proposes the meshing of AlloDerm to decrease the total amount needed for breast reconstruction,while achieving comparable surgical outcomes as using unmeshed alloderm. 展开更多
关键词 ALLODERM acellular dermal matrix breast reconstruction MESHING breast cancer
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部